title: Introduction: Female fertility preservation: innovations and questions.
abstract: Oocyte and ovarian tissue cryopreservation represents one of the most important advances in the field of reproductive medicine and biology. Preserving a woman's potential for becoming a genetic mother is now possible for numerous diseases that could impair female fertility either by themselves or as a result of their treatments. However, female fertility preservation is still at the pioneering level and is thus often considered an experimental treatment either from a technical standpoint or in the clinical situation in which it is discussed. As a consequence, many ethics issues are raised with fertility preservation treatment in infants, adolescents, and young women.
authors.affiliation: University Paris V, Paris, France; Service de Gynécologie Obstétrique, Hôpital Foch, Suresnes, France. Electronic address: frydmanrene@gmail.com.
authors.forename: René
authors.initials: R
authors.lastname: Frydman
authors.affiliation: Service de Médecine de la Reproduction, Hôpital Jean-Verdier, Bondy, France; Université Paris XIII, Bobigny, France; Unité Inserm U1133, Université Paris-Diderot, Paris, France.
authors.forename: Michaël
authors.initials: M
authors.lastname: Grynberg
mesh_terms: D000293:Adolescent; D000367:Age Factors; D015925:Cryopreservation; D004059:Diffusion of Innovation; D005260:Female; D005298:Fertility; D059247:Fertility Preservation / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D007223:Infant; D007247:Infertility, Female / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D009865:Oocytes / Q000637:transplantation; D010053:Ovary / Q000637:transplantation; D011247:Pregnancy; D012307:Risk Factors; D014015:Tissue Banks; D055815:Young Adult
keywords: Fertility preservation; oncofertility